DiaSorin S.p.A. (BIT:DIA)
Italy · Delayed Price · Currency is EUR 82.50
+0.16 (0.19%)
Sep 8, 2025, 1:42 PM CET
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Italy Operating Profit | 104.56M | Log In | Log In | Log In | Log In | Upgrade |
Italy Operating Profit Growth | -22.58% | Log In | Log In | Log In | Log In | Upgrade |
Europe Operating Profit | 24.35M | Log In | Log In | Log In | Log In | Upgrade |
Europe Operating Profit Growth | 0.63% | Log In | Log In | Log In | Log In | Upgrade |
North America Operating Profit | 140.76M | Log In | Log In | Log In | Log In | Upgrade |
North America Operating Profit Growth | -27.79% | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Operating Profit | 1.27M | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Operating Profit Growth | -1957.49% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Operating Profit | -12.61M | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Operating Profit Growth | -204.00% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Italy | 176.52M | Log In | Log In | Log In | Log In | Upgrade |
Italy Growth | -11.51% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 288.15M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 4.93% | Log In | Log In | Log In | Log In | Upgrade |
North America | 618.94M | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | -16.25% | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 101.81M | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Growth | -9.70% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Ex-COVID Immunodiagnostics % of Revenue | 66.20 | Log In | Log In | Log In | Log In | Upgrade |
Ex-COVID Immunodiagnostics % of Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ex-COVID Molecular Diagnostics % of Revenue | 17.20 | Log In | Log In | Log In | Log In | Upgrade |
Ex-COVID Molecular Diagnostics % of Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Licensed Technologies % of Revenue | 14.40 | Log In | Log In | Log In | Log In | Upgrade |
Licensed Technologies % of Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
COVID % of Revenue | 2.20 | Log In | Log In | Log In | Log In | Upgrade |
COVID % of Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |